Navigation Links
Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
Date:4/26/2008

mmon form of the virus worldwide and most difficult to treat, were randomized and treated with one of three treatment regimens:

(1) PEGINTRON 1.5 mcg/kg/week and REBETOL 800-1,400 mg/day;

(2) PEGINTRON 1.0 mcg/kg/week and REBETOL 800-1,400 mg/day; and

(3) Pegasys 180 mcg/week and Copegus 1,000-1,200 mg/day

Patients received up to 48 weeks of combination therapy with 24 weeks of follow-up.

In IDEAL, the combination regimen of Pegasys and Copegus used the recommended doses in accordance with their approved U.S. labeling, which includes a flat dose of Pegasys (180 mcg/week) for all patients regardless of body weight, and 1,000 or 1,200 mg/day of Copegus, adjusted for two weight categories. PEGINTRON was dosed either at 1.5 mcg/kg/week or an investigational combination dose of 1.0 mcg/kg/week with REBETOL at a dose of 800-1,400 mg/day, adjusted by four weight categories.

As a result, 51 percent of patients in the study were assigned the same dose of ribavirin (either REBETOL or Copegus) based on their weight groups, 39 percent of patients in the Pegasys arm were assigned a higher dose of ribavirin and 10 percent of patients in the PEGINTRON arms were assigned a higher dose of ribavirin.

Key Findings from IDEAL

(For the PEGINTRON 1.5 mcg, PEGINTRON 1.0 mcg, and Pegasys combination arms, respectively.)

-- SVR, the primary endpoint of the study, was similar for the three treatment regimens (40 vs. 38 vs. 41 percent, respectively) overall, and among those patients who were assigned equivalent doses of ribavirin based on their weight group (40 vs. 38 vs. 38 percent, respectively) (ITT).(3,4)

-- Predictability of response at early treatment milestones was confirmed in a secondary analysis as an important assessment tool for physicians. More patients in the PEGINTRON combination arms who had undetectable virus (HCV-RNA) in plasma at treatment week 4 or treatment week 12 went on to achieve SVR (positive p
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
2. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
3. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
4. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
5. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
11. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Research and Markets ( ... "Global Suture Industry Report 2015" report ... Industry Report 2015 is a professional and in-depth ... industry. The report provides a basic ... and industry chain structure. The suture market analysis ...
(Date:5/6/2015)... May 6, 2015 Fibich, Leebron, Copeland, Briggs ... billion settlement has been reached to resolve lawsuits involving ... medication Actos. Actos - manufactured by Takeda Pharmaceuticals - ... bladder cancer. Several of the firm,s attorneys were instrumental ... Tommy Fibich - Founding Partner of ...
(Date:5/6/2015)... and PRETORIA, South Africa , ... , cancer kills more people than HIV/AIDS, malaria and tuberculosis ... and 40 percent can be cured with the right treatment[3]. ... African nations are working to build up their radiation therapy ... of all cancer patients worldwide would benefit from radiation therapy[4] ...
Breaking Medicine Technology:Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay ... Ship at Raymond James Stadium for all the “Bucs Babies” ... be drafted into the “Bucs Babies” program last year. ... with children, particularly those born at the Florida Hospitals here ... fans. I really enjoyed my time participating in the festivities, ...
(Date:5/6/2015)... Angeles, CA (PRWEB) May 06, 2015 ... “16 Celebrities on Plastic Surgery ,” compiled quotes ... celebs includes Jennifer Aniston, pop singer Iggy Azalea, and ... indicates their sentiments about having plastic surgery ... statement about society and its expectations of youth and ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Chesapeake ... the state of Virginia to acquire Intuitive Surgical, ... robot. The system upgrade includes enhanced surgical technique ... invasive procedures across a wide spectrum of specialties. ... reduced pain and quicker recovery times. , “As ...
(Date:5/6/2015)... of Prussia, PA (PRWEB) May 06, 2015 ... Process Outsourcing solutions to the Medicare Advantage, Medicare Part ... finalists in the Continuity and Resilience Team category at ... the Business Continuity Institute to recognize the outstanding contribution ... operating in the North America Region, including the USA ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Inversion ... specializes in yoga and Pilates classes, provides personalized ... and products, starting with its new Pilates Ring ... effort of becoming leaner, stronger, more centered and ... offer a fresh venue to healthy fitness through ...
Breaking Medicine News(10 mins):Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... ... visualizes, interprets and optimizes the complex network patterns and flows of social media, communities ... enterprise collaboration. The Social Media Network Analysis workshop is practical, hands-on, low-cost and ... ...
... ... will not keep pace with an increasing number of Alzheimer’s patients forecast in the ... help those suffering from this disease and their stressed-out families. , ... Omaha, NE (PRWEB) April 15, 2010 ...
... and successful anti-obesity program, First Lady Michelle Obama,s ... pregnant women, infants, and pre-school-age children, UCSF experts ... assistant professor of pediatrics, and Melvin Heyman, MD, ... gastroenterology, hepatology and nutrition at UCSF Children,s Hospital, ...
... ... program, First Lady Michelle Obama’s “Let’s Move” campaign must include interventions that target ... ... 2010 -- To be a truly comprehensive and successful anti-obesity program, First Lady ...
... quality of life, experts note , WEDNESDAY, April ... can be a common symptom in patients with ... or amyotrophic lateral sclerosis (ALS). , However, a ... long-term treatment for the problem, researchers say. , ...
... ... Solutions Provider, has signed an agreement to become an Infor channel partner. Through the ... ... is a premier ERP solution that has been deployed by manufacturing companies around the world ...
Cached Medicine News:Health News:Social Media Network Analysis Workshop 2Health News:Social Media Network Analysis Workshop 3Health News:Home Care Businesses Fill Void As Alzheimer's Care Units Decline 2Health News:Home Care Businesses Fill Void As Alzheimer's Care Units Decline 3Health News:Childhood obesity interventions must begin early, UCSF experts say 2Health News:Childhood obesity interventions must begin early, UCSF experts say 3Health News:Childhood Obesity Interventions Must Begin Early, UCSF Experts Say 2Health News:Childhood Obesity Interventions Must Begin Early, UCSF Experts Say 3Health News:Childhood Obesity Interventions Must Begin Early, UCSF Experts Say 4Health News:Treatment Eases Involuntary Laughing, Crying Tied to Alzheimer's, MS 2Health News:Treatment Eases Involuntary Laughing, Crying Tied to Alzheimer's, MS 3Health News:ZSL Partners with Infor to Resell ERP SyteLine & Provide Industry's Most Innovative ERP Solutions 2
... for use in 5 to 8 Fr. access ... Closer S 6F SMC System is indicated for ... common femoral artery access site of patients who ... 5 to 8F sheaths. The Closer S 6F ...
... active lifestyles of todays cardiac surgery patients ... rapid recovery and speedy return to everyday ... vessel harvesting (EVH), clinicians have been able ... a higher standard of care:, Faster ...
... Keratoconus detected early is best corrected ... acuity may still be present, GP lenses ... inevitable. GP lenses will neutralize the distortions ... visual acuity., ,Keratoconus is a fitting challenge ...
... Aumated Immunoassay Analyzer that fits in any lab ... 16 X 16 X 21 inches and weighs ... ideal for physician office laboratories, work stations for ... as well as a dedicated system for specialty ...
Medicine Products: